Обновлено
WHO updated recommendations on HIV clinical management: recommendations for a public health approach
World Health Organization
Инфекционные заболевания 2025БАЗА МЕДИЦИНСКИХ ЗНАНИЙ
Клинические рекомендации
Здесь собраны официальные рекомендации, консенсусные документы и обновления, опубликованные медицинскими обществами и органами здравоохранения.
Официальные и надежные источникиМедицинские общества и органы здравоохранения
Актуальная информацияНепрерывный научный мониторинг
Бесплатный доступ для специалистовДля медицинского сообщества
ПРИЛОЖЕНИЕ ASEM
Клинические рекомендации всегда под рукой
Изучайте официальные медицинские рекомендации и клинические руководства в приложении ASEM.
Скачать приложение ASEMВажные публикации и обновления
Посмотреть последние публикации
Обновлено
2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias
European Society of Cardiology
Кардиология 2025
Официальная публикация
WHO guidelines on the integrated management of obesity in adolescents
World Health Organization
Педиатрия 2026Все рекомендации (524 результатов)
Фильтры
Seasonal Influenza Vaccine Statement 2021–2022
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2022) on “Seasonal Influenza Vaccine Statement 2021–2022”. NACI recommends that the vaccine be offered to six months...
Canadian Immunization Guide Chapter on influenza and statement on seasonal influenza vaccine for 2021–2022
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2022) on “Canadian Immunization Guide Chapter on influenza and statement on seasonal influenza vaccine for 2021–2022”...
Archived 29: Summary of NACI statement of January 25, 2022: Updated recommendations on the use of COVID-19 vaccines in children 5 to 11 years of age [2022-01-25]
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2022) on “Archived 29: Summary of NACI statement of January 25, 2022: Updated recommendations on the use of COVID-19...
Archived 29: Amendment to January 25, 2022: NACI updated recommendations on the use of COVID-19 vaccines in children 5 to 11 years of age
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2022) on “Archived 29: Amendment to January 25, 2022: NACI updated recommendations on the use of COVID-19 vaccines in...
Archived 29: NACI updated recommendations on the use of COVID-19 vaccines in children 5 to 11 years of age [2022-01-25]
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2022) on “Archived 29: NACI updated recommendations on the use of COVID-19 vaccines in children 5 to 11 years of age...
Archived 31: NACI rapid response: Guidance on the use of booster COVID-19 vaccine doses in adolescents 12 to 17 years of age [2022-01-28]
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2022) on “Archived 31: NACI rapid response: Guidance on the use of booster COVID-19 vaccine doses in adolescents 12 t...
Archived 32: NACI rapid response: Updated guidance on COVID-19 vaccination timing for individuals previously infected with SARS-CoV-2 [2022-02-04]
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2022) on “Archived 32: NACI rapid response: Updated guidance on COVID-19 vaccination timing for individuals previousl...
Archived 33: Summary of NACI statement of February 17, 2022: Recommendations on the use of Novavax Nuvaxovid COVID-19 vaccine
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2022) on “Archived 33: Summary of NACI statement of February 17, 2022: Recommendations on the use of Novavax Nuvaxovi...
Archived 33: Recommendations on the use of Novavax Nuvaxovid COVID-19 vaccine [2022-02-17]
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2022) on “Archived 33: Recommendations on the use of Novavax Nuvaxovid COVID-19 vaccine [2022-02-17]”. NACI recommend...
Archived 34: Summary of NACI statement of March 11, 2022: Recommendations on the use of Medicago COVID-19 vaccine (Covifenz)
National Advisory Committee on Immunization
Official National Advisory Committee on Immunization document (2022) on “Archived 34: Summary of NACI statement of March 11, 2022: Recommendations on the use of Medicago COVID-19 v...